Engineered and construction of pDS132::∆virG as suicide vector for targeted gene deletion of virG from Shigella flexneri 2a in order to generation a live attenuated Shigella vaccine

Authors

Abstract:

Background & Objective: Shigella are Gram negative bacteria capable of inducing their entry into non-phagocytic cells via secretion of various effector proteins called invasion plasmid antigens (Ipas). The most important of them is VirG protein. Live attenuated Shigella vaccines have indicated promise in inducing protective immune responses in human clinical trials. In current situation, constructions of Shigella vaccine candidate strains based on classical allelic exchange systems are considered. The aim of this research was engineered and constructed pDS132::∆virG as a suicide plasmid for targeted deletion regions of virG gene by using allele exchange method in Shigella flexneri 2a. Method & Materials: In this applied study, species and serotype of shigella was confirmed by using serological and Polymerase Chain Reaction (PCR) tests. Detection primers of virG gene were designed and cloned to pGEM-5zf vector and finally, sequencing was done. According to virG restriction enzyme map, 1751 bp of virG gene was removed by using of HincП restriction enzyme and the ∆virG was successfully constructed. The pGEM∆virG vector was digested by use of SphI and SalI enzymes and then cloned to pSD132 as suicide vector. Precision of process were verified through phenotype and genotype experiment. Results: The Shigella flexneri type 2a strain was verified by serological and PCR tests. Sequence of the virG gene in native strain was sequentially identical with the strains submitted in the Gene-Bank database. Since the pDS132::∆virG contains 1484 bp which derived from virG gene, therefore, it can be utilized for interference in virG gene as specific suicide vector in shigella flexneri 2a. Conclusion: Application of suicide systems facilitated mutant construction in more specific and effective method in comparison with the other early techniques such as serial passage.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

λ-Red-Recombineering Live Attenuated ΔipaD Shigella dysenteriae from Iranian Isolates as A Candidate of Vaccine

Shigella species (spp.) are gram-negative bacteria that are responsible for shigellosis. Although it can be controlled via antibiotics, increasing number of antibiotic resistant isolates of Shigella have been reported. Therefore, other strategies such as production of specific vaccine against this organism could be a suitable therapeutic approach. Attenuated live vaccines produced by gene delet...

full text

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.

The Shigella flexneri 2a SC602 vaccine candidate carries deletions of the plasmid-borne virulence gene icsA (mediating intra- and intercellular spread) and the chromosomal locus iuc (encoding aerobactin) (S. Barzu, A. Fontaine, P. J. Sansonetti, and A. Phalipon, Infect. Immun. 64:1190-1196, 1996). Dose selection studies showed that SC602 causes shigellosis in a majority of volunteers when 3 x 1...

full text

Live Attenuated Shigella as a Diarrheal Vaccine And/or Mucosal Delivery Vector for Dna Vaccines

Several live attenuated Shigella vaccines of different serotypes have been shown to be safe, immunogenic, and in one case effective against challenge with virulent strains. The ability to invade epithelial cells remains critical for the success of these vaccine candidates. Live, orally administered Shigella vaccine derivatives are also being evaluated as multivalent mucosal vaccines able to del...

full text

λ-red-recombineering live attenuated δipad shigella dysenteriae from iranian isolates as a candidate of vaccine

shigella species (spp.) are gram-negative bacteria that are responsible for shigellosis. although it can be controlled via antibiotics, increasing number of antibiotic resistant isolates of shigella have been reported. therefore, other strategies such as production of specific vaccine against this organism could be a suitable therapeutic approach. attenuated live vaccines produced by gene delet...

full text

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.

A phase 1 clinical trial was conducted among 35 healthy adult volunteers to evaluate the safety, immunogenicity, and shedding of different doses of CVD 1207, a live attenuated Shigella flexneri 2a vaccine candidate with specific deletion mutations in virG, sen, set, and guaBA. CVD 1207 retains the ability to invade epithelial cells but cannot effectively spread intercellularly after invasion (D...

full text

Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.

We studied the induction of antigen-specific IgA memory B cells (B(M)) in volunteers who received live attenuated Shigella flexneri 2a vaccines. Subjects ingested a single oral dose of 10(7), 10(8) or 10(9) CFU of S. flexneri 2a with deletions in guaBA (CVD 1204) or in guaBA, set and sen (CVD 1208). Antigen-specific serum and stool antibody responses to LPS and Ipa B were measured on days 0, 7,...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue 4

pages  197- 205

publication date 2012-02

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023